USD  EUR GBP
CAD AUD CHF
We accept:
 
Language:
  us uk it es fr de
Order by phone
Find a pill by name:
  Your cart: $0.00(0 items)
Checkout
Male enhancement pills Men's health pills Female enhancement pills Weight loss pills Skin care pills Pills for Pets
Sleep aid pills General health pills Women's health pills Stop smoking pills Dental whitening pills Pain relief pills
Healthy bones pills Anti-fungus pills Anti acidity pills Anti-herpes pills Anti-diabetic pills Antibiotic pills
Anti-allergic pills Cholesterol and blood preassure pills Anti-depressant anxiety pills Pills for body-building Hypnotherapy
Gums Patches Erectile dysfunction pills

The Best-Selling Drugs In America

Lipitor, the cholesterol-lowering treatment, remains the best-selling drug in America. But Pfizer, the drug’s maker, is facing renewed competition from biotechs like Amgen that were hardly on the map a decade ago– and renewed threats from cheap generic drugs.That’s the picture from newly released data from IMS Health, a pharmaceutical information and consulting company that independently keeps track of how often medicines are prescribed and how much revenue they are generating. IMS has provided to Forbes a list of the top 20 medicines by U.S. sales.

lipitor

lipitor

#1
LIPITOR
Treats: High cholesterol
Pfizer
$8.4 billion
+8%
zocor

zocor

#2
ZOCOR
Treats: High cholesterol
Merck
$4.4 billion
-5%
Nexium

Nexium

#3
NEXIUM
Treats: Heartburn
AstraZeneca
$4.4 billion
+15%
Prevacid

Prevacid

#4
PREVACID
Treats: Heartburn
Abbott & Takeda
$3.8 billion
-2%
Advair Diskus

Advair Diskus

#5
ADVAIR DISKUS
Treats: Asthma
GlaxoSmithKline
$3.6 billion
+22%
Plavix

Plavix

#6
PLAVIX
Treats: Heart disease
Bristol-Myers Squibb & Sanofi-Aventis
$3.5 billion
+15%
Zoloft

Zoloft

#7
ZOLOFT
Treats: Depression
Pfizer
$3.1 billion
-2%
epogen

epogen

#8
EPOGEN
Treats: Anemia
Amgen
$3.0 billion
-1%
Procrit

Procrit

#9
PROCRIT
Treats: Anemia
Johnson & Johnson
$3.0 billion
-9%
Aranesp

Aranesp

#10
ARANESP
Treats: Anemia
Amgen
$2.8 billion
+46%
Enbrel

Enbrel

#11
ENBREL
Treats: Rheumatoid arthritis
Amgen & Wyeth
$2.7 billion
+36%
Norvasc

Norvasc

#12
NORVASC
Treats: High blood pressure
Pfizer
$2.6 billion
+8%
Seroquel

Seroquel

#13
SEROQUEL
Treats: Schizophrenia
AstraZeneca
$2.6 billion
+25%
Effexor xr

Effexor xr

#14
EFFEXOR XR
Treats: Depression
Wyeth
$2.6 billion
-2%
Zyprexa

Zyprexa

#15
ZYPREXA
Treats: Schizophrenia
Eli Lilly
$2.5 billion
-16%
Singulair

Singulair

#16
SINGULAIR
Treats: Asthma & Allergies
Merck
$2.5 billion
+14%
Protonix

Protonix

#17
PROTONIX
Treats: Heartburn
Wyeth
$2.4 billion
+0%
Risperdal

Risperdal

#18
RISPERDAL
Treats: Schizophrenia
Johnson & Johnson
$2.3 billion
+5%
Neulasta

Neulasta

#19
NEULASTA
Treats: Chemotherapy side effects
Amgen
$2.2 billion
+30%
Remicade

Remicade

#20
REMICADE
Treats: Rheumatoid arthritis
Johnson & Johnson
$2.2 billion
+12%

Source: IMS Health, a healthcare information company.

Tags: ,

Leave a Reply

You must be logged in to post a comment.